Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,380,995
-
Share change
-
-18,284
-
Total reported value
-
$37,873,739
-
Price per share
-
$4.52
-
Number of holders
-
48
-
Value change
-
-$25,070
-
Number of buys
-
16
-
Number of sells
-
22
Institutional Holders of APPLIED GENETIC TECHNOL CORP - COM (AGTC) as of Q4 2019
As of 31 Dec 2019,
APPLIED GENETIC TECHNOL CORP - COM (AGTC) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,380,995 shares.
The largest 10 holders included
INTERWEST VENTURE MANAGEMENT CO, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, VANGUARD GROUP INC, 683 Capital Management, LLC, DAFNA Capital Management LLC, ALTRINSIC GLOBAL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, and BlackRock Inc..
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.